JPMorgan downgrades this solar stock after a massive move higher in recent months
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Citigroup hires two senior JPMorgan bankers to boost investment banking
-- Citigroup Inc (NYSE:C). is hiring two senior bankers from JPMorgan Chase & Co. (NYSE:JPM) to strengthen its investment banking division, according to a Bloomberg report on Wednesday. Aloke Gupte will join Citigroup as global co-head of equity capital markets, working alongside Doug Adams. Gupte will be based in London for this position. Alex Watkins will take on the newly-created role of head of technology financing at Citigroup. Watkins will relocate to San Francisco and handle both debt and equity financing in the technology sector. Both Gupte and Watkins previously ran JPMorgan's equity capital markets business outside the United States. The new executives will report to Achintya Mangla, who leads Citigroup's financing business. Related articles Citigroup hires two senior JPMorgan bankers to boost investment banking Clients buying into summer rally, bracing for later pullback, says BofA's Hartnett Surge of 50% since our AI selection, this chip giant still has great potential Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
JPMorgan Upgrades Ventas (VTR) to 'Overweight' with $72 Price Target
Ventas, Inc. (NYSE:VTR) is one of Goldman Sachs' top REIT stock picks. On June 23, JPMorgan upgraded Ventas' stock rating from 'Neutral' to 'Overweight'. The firm also increased the price target on Ventas shares from $70 to $72. The upgrade reflects a more positive outlook compared to the previous neutral stance. A senior couple walking hand-in-hand in a senior housing facility. One of the factors JPMorgan cited was Ventas' 'strong internal and external growth trends.' The firm particularly pointed to the company's double-digit same-store net operating income (NOI) growth in its senior housing operating portfolio (SHOP), Ventas' largest portfolio segment. JPMorgan noted that Ventas has maintained a consistent flow of acquisition opportunities, supporting external growth. The investment firm also cited good visibility for above-average normalized funds from operations (NFFO) per share growth over the next few years. Compared to Ventas's closest peer, JPMorgan noted that Ventas offers more value on an implied capitalization rate basis, though potentially with somewhat less growth potential. The firm observed that the expected external growth recovery in the overall REIT sector has not broadly materialized, making Ventas's external growth dynamics stand out. Ventas, Inc. (NYSE:VTR) is a healthcare-focused REIT with a portfolio of approximately 1,400 properties across the U.S., Canada, and the U.K., including senior housing communities, medical office buildings, and life science centers. Its growth is anchored in the senior housing operating portfolio (SHOP), which delivered double-digit NOI gains in early 2025, supported by rising occupancy and data-driven asset management. While we acknowledge the potential of VTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Healthcare Stocks: Top 10 Stock Picks and 11 Best Green Energy Penny Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
High Dividend Yield and Monthly Payouts? This ETF Offers Both.
Selling covered calls is becoming an increasingly common income-producing strategy. This approach, however, comes with notable downsides and uncertainties. For some, the JPMorgan ETF's monthly dividends and strong yield may be worth it. 10 stocks we like better than JPMorgan Equity Premium Income ETF › There's no such thing as a perfect investment -- each one is ultimately a trade-off. Higher-growth stocks are usually riskier, for instance, while income-producing holdings often don't produce a great deal of capital appreciation. For investors who want (or need) monthly investment income to help cover their living expenses, however, the JPMorgan Equity Premium Income ETF (NYSEMKT: JEPI) is an intriguing prospect. Not only does its trailing yield stand at an impressive 8.6%, but it holds stocks that at least offer some potential upside. The question is, is it the right choice for you? For the record, you can find higher yields from monthly dividend ETFs. The Global X SuperDividend ETF's current yield is an incredible 9.9%, for instance, while the Invesco KBW High Dividend Yield Financial ETF boasts a dividend yield of 12.5%. But there is a trade-off. Global X's fund owns a whole lot of smaller foreign stocks that can perform unpredictably, and often badly. This ETF has dramatically underperformed the S&P 500 since the fund's inception back in 2011, and its dividend payments made in the meantime haven't made up the difference at any point during that stretch. The Invesco fund has fared better, but is still not a straight-up investment in the broad market. Its heavy exposure to real estate investment trusts (REITs) and similar asset management investments has limited its upside, largely due to the economic environment. So how is the JPMorgan Equity Premium Income ETF different, and better? First and foremost, it holds the same stocks as the aforementioned S&P 500 (although the size of these holdings tends to be a bit better balanced than the top-heavy S&P 500). There's a significant twist to this idea, though. This ETF's managers are constantly selling call options against the fund's stock holdings, generating recurring income as a result. This income is then used to pay ETF's monthly dividend. Great, you say, but what's a call option? Keep reading. In simplest terms, a call option is a bullish bet that a stock (or index) will rise to or above a particular price before or by a specific date. Qualified traders and institutions can pay to make such a wager, but they must pay a counterparty to make what's essentially the opposite bet -- a bet that the stock or index in question won't reach that price level by the specified date. Indeed, this betting is so well organized that these options trade on exchanges and are dynamically priced all throughout the day just like stocks. That's what JPMorgan is doing with JEPI. It's collecting money for being willing to take, or "sell," the other side of bullish bets someone else is making by buying call options, using its own underlying stock holdings as collateral. It's called a "covered call" strategy, in fact. JPMorgan is "covered" if it needs to sell or deliver a stock per the call option's requirements. Sounds complicated, and even a little risky? It can be. As was noted, if the other party is right about the stock in question rising in value, JPMorgan might be required to sell shares of one of more of its S&P 500 stocks the fund is holding. That's not what it wants in the long run, though. The fund's managers would rather keep all of its stock holdings all the time. The thing is, JPMorgan might still be making that sale at a profit. It also still keeps any money collected for selling the covered call in the first place even if it's forced to fork over those shares. That's far from being disastrous. The best-case scenario, of course, is that the call option in question expires without its buyer ever deciding to use (or "exercise") the option. This takes JPMorgan's risk off the table, freeing it up to make another similar bet, and then another, and then another, in perpetuity. This is why selling covered calls can be a savvy way of consistently monetizing what are ultimately long-term investments. But there's a catch. More than one, actually. As was noted above, every investment imposes a trade-off. JEPI is no exception. Perhaps the chief trade-off of using covered calls to generate continual income is that -- even on a net basis -- it underperforms its most relevant benchmark index. As the graphic below plainly shows, even adding in its dividend payments funded by the sale of covered calls, the JPMorgan Equity Premium Income ETF has trailed the overall return of the S&P 500 since the fund launched back in the middle of 2020. Blame it on the covered call strategy itself. The market has a knack for preventing anyone -- even brilliant traders -- from gaining and keeping a market-beating edge for too long. Indeed, it often punishes the effort with a subpar performance. The other trade-off? Although the trailing dividend yield of 8.6% is compelling, the underlying dividend isn't exactly consistent. The early July payment of just over $0.40 per share is much lower than June's per-share payment of $0.54, for instance. Early this year, the monthly payment fell to just a little over $0.32. If you need this income to pay your bills, owning this fund to do it could prove stressful. In this instance, blame it on the way call (and put) options are priced. Their values are impacted by unpredictable factors ranging from market volatility to interest rates to the direction the market itself is thought to be moving. As such, sellers of these options may not always get a great price. So JEPI is a no-go as a monthly dividend investment? Well, that's not necessarily the case at all. Despite its downsides, the strong yield of 8.6% here is still attractive even if it changes from time to time. You'd probably just want to buffer its payment inconsistencies by holding other, more consistent income investments even if they offer smaller yields. There's also at least some potential for capital appreciation with this ETF's strategy. You won't achieve as much as you might with a stake in the SPDR S&P 500 ETF Trust. But you also wouldn't be collecting the sort of dividends with the S&P 500 ETF that you would with the JPMorgan Equity Premium Income ETF, and you'd certainly see more long-term gains with this fund then you would with interest-bearing bonds. Again, trade-offs. Bottom line? As is always the case, don't weigh potential ownership of this exchange-traded fund in a vacuum. Think about your particular needs and risk tolerances, and determine how it might fit in with the rest of your holdings. You may actually find a place for JEPI in your portfolio. The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did JPMorgan Equity Premium Income ETF make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,060% vs. just 179% for the S&P — that is beating the market by 881.02%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $679,653!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,046,308!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 James Brumley has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. High Dividend Yield and Monthly Payouts? This ETF Offers Both. was originally published by The Motley Fool
